drugset / Trial / NCT00725738

Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction: TRACIA STUDY.

NCT00725738

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the ejection fraction (EF) increase at 6 months follow up and major adverse cardiovascular events (MACE) after intracoronary autologous stem cell transplantation in ST elevation myocardial infarction patients versus a control group.

Timeline

Start
2008-05
Primary completion
2009-12
Completion
2009-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor Cells Unknown Other